Showing results (11-20 of 179) with videos related to
Sort By:
Pageof 18
Mediterranean Journal of Hematology and Infectious Diseases|November 22, 2012
Advances in the treatment of malariaFrancesco Castelli, Lina Rachele Tomasoni, Alberto MatteelliBMC Infectious Diseases|September 20, 2014
Sustained virological response to peginterferon therapy in patients infected with HCV (genotypes 2 and 3), with or without HIVSilvia Odolini, Silvia Amadasi, Carlo Cerini, et al.Infectious Disease Reports|July 13, 2016
New Antituberculosis Drugs: From Clinical Trial to Programmatic UseGina Gualano, Susanna Capone, Alberto Matteelli, et al.Infectious Disease Clinics of North America|September 12, 2012
Visiting relatives and friends (VFR), pregnant, and other vulnerable travelersAlberto Matteelli, Anna Cristina C Carvalho, Sara BigoniInternational Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 24, 2025
Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis eliminationAlberto Matteelli, Sofia Lovatti, Benedetta Rossi, et al.Travel Medicine and Infectious Disease|December 4, 2016
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in EuropeAlberto Matteelli, Rosella Centis, Giorgia Sulis, et al.Expert Review of Anti-Infective Therapy|November 28, 2007
Antimicrobial prevention and therapy for travelers' infectionFrancesco Castelli, Susanna Capone, Barbara Pedruzzi, et al.Current Opinion in Infectious Diseases|January 24, 2022
Mycobacterial skin infectionGiulia Gardini, Natalia Gregori, Alberto Matteelli, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2023
Programmatic management of tuberculosis preventive therapy: Past, present, futureAlberto Matteelli, Sofia Lovatti, Anita Sforza, et al.Clinical Pharmacokinetics|April 30, 2014
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycinsMario Regazzi, Anna Cristina Carvalho, Paola Villani, et al.Pageof 18